213 related articles for article (PubMed ID: 2459161)
21. B-cell activation in vitro by helper T cells specific to region alpha 146-162 of Torpedo californica nicotinic acetylcholine receptor.
Rosenberg JS; Oshima M; Atassi MZ
J Immunol; 1996 Oct; 157(7):3192-9. PubMed ID: 8816433
[TBL] [Abstract][Full Text] [Related]
22. Tolerance to a dominant T cell epitope in the acetylcholine receptor molecule induces epitope spread and suppresses murine myasthenia gravis.
Wu B; Deng C; Goluszko E; Christadoss P
J Immunol; 1997 Sep; 159(6):3016-23. PubMed ID: 9300727
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune T cell recognition of human acetylcholine receptor: the sites of T cell recognition in myasthenia gravis on the extracellular part of the alpha subunit.
Oshima M; Ashizawa T; Pollack MS; Atassi MZ
Eur J Immunol; 1990 Dec; 20(12):2563-9. PubMed ID: 2269324
[TBL] [Abstract][Full Text] [Related]
24. Specific activation of lymphocytes against acetylcholine receptor in the thymus in myasthenia gravis.
Fujii Y; Hashimoto J; Monden Y; Ito T; Nakahara K; Kawashima Y
J Immunol; 1986 Feb; 136(3):887-91. PubMed ID: 2416838
[TBL] [Abstract][Full Text] [Related]
25. In vitro proliferative responses and antibody titers specific to human acetylcholine receptor synthetic peptides in patients with myasthenia gravis and relation to HLA class II genes.
Brocke S; Brautbar C; Steinman L; Abramsky O; Rothbard J; Neumann D; Fuchs S; Mozes E
J Clin Invest; 1988 Dec; 82(6):1894-900. PubMed ID: 2461962
[TBL] [Abstract][Full Text] [Related]
26. T cell receptor expression and differential proliferative responses by T cells specific to a myasthenogenic peptide.
Kirshner SL; Waisman A; Zisman E; Ben-Nun A; Mozes E
Cell Immunol; 1997 Aug; 180(1):20-8. PubMed ID: 9316635
[TBL] [Abstract][Full Text] [Related]
27. T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
Wang ZY; Qiao J; Melms A; Link H
Cell Immunol; 1993 Dec; 152(2):394-404. PubMed ID: 8258147
[TBL] [Abstract][Full Text] [Related]
28. The autoimmune response of different mouse strains to T-cell epitopes of the human acetylcholine receptor alpha subunit.
Brocke S; Dayan M; Rothbard J; Fuchs S; Mozes E
Immunology; 1990 Apr; 69(4):495-500. PubMed ID: 1692300
[TBL] [Abstract][Full Text] [Related]
29. Human acetylcholine receptor presentation in myasthenia gravis. DR restriction of autoimmune T epitopes and binding of synthetic receptor sequences to DR molecules.
Manfredi AA; Yuen MH; Moiola L; Protti MP; Conti-Tronconi BM
J Immunol; 1994 Apr; 152(8):4165-74. PubMed ID: 7511671
[TBL] [Abstract][Full Text] [Related]
30. A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes.
Nagvekar N; Moody AM; Moss P; Roxanis I; Curnow J; Beeson D; Pantic N; Newsom-Davis J; Vincent A; Willcox N
J Clin Invest; 1998 May; 101(10):2268-77. PubMed ID: 9593783
[TBL] [Abstract][Full Text] [Related]
31. A disease-related epitope of Torpedo acetylcholine receptor. Residues involved in I-Ab binding, self-nonself discrimination, and TCR antagonism.
Wall KA; Hu JY; Currier P; Southwood S; Sette A; Infante AJ
J Immunol; 1994 May; 152(9):4526-36. PubMed ID: 8157967
[TBL] [Abstract][Full Text] [Related]
32. MHC class II presentation of human acetylcholine receptor in Myasthenia gravis: binding of synthetic gamma subunit sequences to DR molecules.
Yuen MH; Macklin KD; Conti-Fine BM
J Autoimmun; 1996 Feb; 9(1):67-77. PubMed ID: 8845056
[TBL] [Abstract][Full Text] [Related]
33. Use of synthetic peptides to establish anti-human acetylcholine receptor CD4+ cell lines from myasthenia gravis patients.
Protti MP; Manfredi AA; Straub C; Wu XD; Howard JF; Conti-Tronconi BM
J Immunol; 1990 Mar; 144(5):1711-20. PubMed ID: 1968487
[TBL] [Abstract][Full Text] [Related]
34. Immunomodulation by a dual altered peptide ligand of autoreactive responses to the acetylcholine receptor of peripheral blood lymphocytes of patients with myasthenia gravis.
Dayan M; Sthoeger Z; Neiman A; Abarbanel J; Sela M; Mozes E
Hum Immunol; 2004 Jun; 65(6):571-7. PubMed ID: 15219376
[TBL] [Abstract][Full Text] [Related]
35. T cell responses to human recombinant acetylcholine receptor-alpha subunit in myasthenia gravis and controls.
Sun JB; Harcourt G; Wang ZY; Hawke S; Olsson T; Fredrikson S; Link H
Eur J Immunol; 1992 Jun; 22(6):1553-9. PubMed ID: 1376263
[TBL] [Abstract][Full Text] [Related]
36. TCR gene usage in experimental autoimmune myasthenia gravis pathogenesis. Usage of multiple TCRBV genes in the H-2b strains.
Wu B; Shenoy M; Goluszko E; Kaul R; Christadoss P
J Immunol; 1995 Apr; 154(7):3603-10. PubMed ID: 7897239
[TBL] [Abstract][Full Text] [Related]
37. T-helper epitopes on human nicotinic acetylcholine receptor in myasthenia gravis.
Moiola L; Protti MP; Manfredi AA; Yuen MH; Howard JF; Conti-Tronconi BM
Ann N Y Acad Sci; 1993 Jun; 681():198-218. PubMed ID: 7689306
[TBL] [Abstract][Full Text] [Related]
38. Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes.
Ofosu-Appiah W; Mokhtarian F; Shirazian D; Grob D
J Lab Clin Med; 1994 Aug; 124(2):231-41. PubMed ID: 8051487
[TBL] [Abstract][Full Text] [Related]
39. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptor.
Shenoy M; Oshima M; Atassi MZ; Christadoss P
Clin Immunol Immunopathol; 1993 Mar; 66(3):230-8. PubMed ID: 7679342
[TBL] [Abstract][Full Text] [Related]
40. T cell receptor V beta 15 dominates the antiacetylcholine receptor response in Lewis rat T cell lines.
Smith LR; Kono DH; Asthana D; Balderas RS; Fujii Y; Lindstrom J; Theofilopoulos AN
J Immunol; 1994 Mar; 152(5):2596-600. PubMed ID: 8133067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
